India's CDSCO plans e-filing system; Japanese printer Dai Nippon aims for cultured cell sheets;

> India's CDSCO has asked drug industry bodies to nominate experts to help develop an electronic system for filing, processing, and tracking applications. Release (PDF)

> Kemwell Biopharma said its oral solids manufacturing facility located in Bangalore successfully completed its second U.S. Food and Drug Administration inspection. Release (PDF)

> Johnson & Johnson ($JNJ) CEO Alex Gorsky told the WSJ that China and Japan are in focus. Report

> Japanese printing company Dai Nippon Printing reinvented its business model with mass production technology for cultured cell sheets. Report

> Nasdaq-listed China Jo-Jo Drugstores ($CJJD) said its online pharmacy saw sales increase 200% to $1.6 million in the quarter ended March 31. Release